Raloxifene enhances osteoblastic differentiation in adipose derived stem cells via nitric oxide pathway

Xiang LU,Jiang-ning CHEN,Jun-feng ZHANG
2011-01-01
Abstract:Aim: To explore the effects of raloxifene on osteoblastic differentiation. Methods: adipose derived stem cells(ADSCs) were obtained from rats and identified for their multilineage differentiation potential. Different concentrations of raloxifene (0, 0.01, 0.1, 1 μmol·L-1) were added into culture medium with or without N-nitro-L-arginine methyl ester (L-NAME, 1 mmol·L-1), which is used as a non-selective inhibitor of nitric oxide synthase(NOS). After 14-28 d of cultivation, the expression of osteoblast-specific markers were measured. Results: Raloxifene (0.01, 0.1, 1 μmol·L-1) increased NO production and enhanced the expression of osteoblastic gene (alkaline phosphatase , ALP; bone morphogenetic protein 2,BMP2;type I collagen, Col-I) as well as enhanced calcium deposition. Meanwhile, supplementation of L-NAME (1 mmol ·L -1) significantly reversed the raloxifene-induced NO formation and osteogenic marker genes expression. Conclusions Raloxifene may induce the osteoblastic differentiation of ADSCs through NO pathway.
What problem does this paper attempt to address?